Market News AIOpen the app

UBS changes its price goal for Medpace to $700, up from $673.

OpinionRead the original at marketscreener.com
Neutral

UBS raised its price goal for Medpace but kept its Neutral rating. The note gives no new details about the company's business, so it does not change its prospects.

MEDP · Medpace Holdings, Inc.

AI read · Neutral

The AI's read

The higher price goal points to a more favorable estimate, but UBS kept its Neutral rating. The note gives no new details about Medpace's business, so it does not change how we read the company.

Get alerts for MEDP

Follow Medpace Holdings, Inc. (MEDP) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for MEDP
Free on the App Store and Google Play, or on the web.